for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Novozymes A/S

NZYMb.CO

Latest Trade

293.50DKK

Change

-3.80(-1.28%)

Volume

446,201

Today's Range

291.70

 - 

298.80

52 Week Range

260.10

 - 

363.10

As of on the Copenhagen Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
297.30
Open
297.00
Volume
446,201
3M AVG Volume
10.15
Today's High
298.80
Today's Low
291.70
52 Week High
363.10
52 Week Low
260.10
Shares Out (MIL)
287.63
Market Cap (MIL)
70,536.33
Forward P/E
26.44
Dividend (Yield %)
1.51

Next Event

Novozymes A/S at Sanford C Bernstein Strategic Decisions CEO Conference

Latest Developments

More

Novozymes Makes Organizational Changes

Lars Green Will Join Novozymes As EVP And CFO

Novozymes Expects To Announce New CFO

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Novozymes A/S

Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.

Industry

Chemical Manufacturing

Contact Info

Krogshoejvej 36

+45.44.460000

https://www.novozymes.com/

Executive Leadership

Joergen Buhl Rasmussen

Independent Chairman of the Board

Peder Holk Nielsen

President, Chief Executive Officer

Agnete Raaschou-Nielsen

Independent Vice Chairman of the Board

Thomas Videbaek

Chief Operating Officer; Executive Vice President, Research, Innovation & Supply

Anders Lund

Executive Vice President, Household Care & Technical

Key Stats

3.32 mean rating - 19 analysts
Sell
Hold
Buy
Revenue (MM, DKK)

2016

14.1K

2017

14.5K

2018

14.4K

2019(E)

14.6K
EPS (DKK)

2016

10.060

2017

10.490

2018

11.030

2019(E)

11.244
Price To Earnings (TTM)
26.58
Price To Sales (TTM)
4.93
Price To Book (MRQ)
7.77
Price To Cash Flow (TTM)
16.06
Total Debt To Equity (MRQ)
42.23
LT Debt To Equity (MRQ)
24.25
Return on Investment (TTM)
22.69
Return on Equity (TTM)
16.65

Latest News

Novozymes says Indian tariffs hits sales in its Monsanto alliance in Q1 -CFO

Danish enzymes maker Novozymes' posted first-quarter earning slightly above forecasts, but sales through its BioAg alliance with U.S. seeds company Monsanto Co were hit by Indian tariffs, its new CFO said on Wednesday.

Novozymes sets up Turkish project to keep flatbreads fresh for longer

Danish enzymes maker Novozymes has invested in a new lab in Turkey to develop baking enzymes that help to prevent flatbreads traditionally eaten across the Middle East and Africa from going stale.

UPDATE 1-Novozymes results miss estimates as household care drags

Danish enzymes maker Novozymes reported fourth-quarter results below market expectations on Wednesday as organic growth at its biggest division, Household Care, declined.

BRIEF-Novozymes Appoints Prisca Havranek-Kosicek New CFO

* PRISCA HAVRANEK-KOSICEK NEW CFO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

MOVES-Pandora poaches communications director from Novozymes

Danish jewellery maker Pandora said in a statement on Wednesday:

BRIEF-Novozymes CEO Sells 50,000 Of Own Shares

* CEO SELLS 50.000 OF OWN SHARES IN COMPANY FOR A TOTAL VALUE OF DKK 17.2 MILLION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Novozymes completes share buyback program

* NOVOZYMES HAS NOW COMPLETED ANNOUNCED SHARE BUYBACK PROGRAM OF B SHARES WORTH UP TO DKK 2 BILLION IN TOTAL DURING 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Novozymes shares surge as bioenergy tops expectations

Denmark's Novozymes reported third-quarter sales and earnings ahead of forecasts on Wednesday and raised its outlook as more powerful enzymes products drove demand from ethanol makers, sending its shares up six percent to a two-year high.

BRIEF-Novozymes Q3 EBIT above expectations at DKK 1.06 bln

* NOVOZYMES - STILL SOME UNCERTAINTY REGARDING AGRICULTURE-RELATED MARKETS IN Q4

BRIEF-Novozymes launches two ethanol enzyme products in Europe

DANISH ENZYMES PRODUCER NOVOZYMES ANNOUNCES

Novozymes shares fall as Q2 pressured by detergent makers, Monsanto alliance

Danish enzymes maker Novozymes undershot market expectations in the second quarter pressured by cost cuts at detergent makers and a changed sales pattern in its cooperation with Monsanto.

BRIEF-Novozymes ‍Q2 EBIT at DKK 963 mln, below expectations

* Q2 EBIT MARGIN AT 28.2%, EXCLUDING REORGANIZATION COSTS (Q2 2016: 28.0%)

BRIEF-Novozymes CFO steps down

* BENNY D. LOFT TO STEP DOWN AS CFO AND EXECUTIVE VICE PRESIDENT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Novozymes says co, Heinz-Jürgen Bertram mutually decided that he will resign from co's board with effect as of June 8, 2017

* Novozymes - Co, Heinz-Jürgen Bertram have mutually decided that Heinz-Jürgen Bertram will resign from Novozymes' board with effect as of June 8, 2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

REFILE-UPDATE 1-Novozymes shares rise to 9-month high after Q1 earnings

Danish enzymes maker Novozymes posted slightly better-than-expected revenues for the first quarter on Wednesday and said it would launch a new product in the autumn, sending its shares up more than 5 percent to a nine-month high.

BRIEF-Novozymes Q1 EBIT up at DKK 1.01 billion, in line with expectations

* "GOOD START TO 2017 WITH PROGRESS ON OUR STRATEGIC PRIORITIES."

BRIEF-Novozymes, Boehringer announce strategic collaboration in probiotics for poultry hatcheries

* Novozymes and Boehringer Ingelheim announce strategic collaboration in probiotics for poultry hatcheries

BRIEF-Dong Energy to build biogas plant for Novo Nordisk, Novozymes residues

* Says will in cooperation with Bigadan build a large-scale biogas plant

BRIEF-Coor Service Management Holding signs agreement with Novozymes in Denmark

* Delivery to Novozymes starts May 1 Source text: http://bit.ly/2mviZql

BRIEF-Novozymes President and CEO buys 27,700 shares at DKK 6,997,574

* President and CEO Peder Holk Nielsen buys 27,700 shares in Novozymes at 6,997,574 Danish crowns ($1 million) Source text for Eikon:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up